Role of ferritin and ferroportin genes in unexplained hyperferritinaemia

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

A large body of evidence indicates that the level of serum ferritin parallels the concentration of storage iron within the body, regardless of the cell type in which it is stored. Elevated serum ferritin levels, in the absence of inflammation and liver disease, are currently taken to indicate increased iron stores and require further investigation to determine the site of iron overload. Until recently, the only genetic disorder with elevated serum ferritin levels known in Western countries was hereditary HLA-related HFE-related genetic haemochromatosis in Caucasians (HFE, OMIM 235200), and a high serum ferritin in apparently healthy persons was considered suggestive of this disease. In the last few years, at least two novel genetic disorders of iron metabolism presenting as unexplained hyperferritinaemia have been recognized. The first one is hereditary hyperferritinaemia/cataract syndrome (HHCS, OMIM 600886). HHCS arises from various point mutations or deletions within a protein binding sequence in the 5′-UTR of the L-ferritin mRNA that results in increased efficiency of L-ferritin translation. The second one is haemochromatosis type 4, or HFE4 (OMIM 606069), or ferroportin disease. In this latter condition, reticuloendothelial iron overload and hyperferritinaemia are caused by loss-of-function mutations in the SLC11A3 gene that mainly impair macrophage iron recycling. These genetic disorders should be taken into account in the differential diagnosis of unexplained hyperferritinaemia.

Original languageEnglish
Pages (from-to)251-263
Number of pages13
JournalBest Practice and Research: Clinical Haematology
Volume18
Issue number2 SPEC. ISS.
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Ferritins
Genetic Databases
Inborn Genetic Diseases
Iron
Genes
Apoferritins
Iron Overload
Serum
Hemochromatosis
5' Untranslated Regions
Recycling
Point Mutation
Protein Binding
Liver Diseases
Differential Diagnosis
Macrophages
Inflammation
Metabolism
Liver
Messenger RNA

Keywords

  • Cataract
  • Ferritin
  • Ferroportin
  • Hyperferritinaemia
  • Iron

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Role of ferritin and ferroportin genes in unexplained hyperferritinaemia. / Cazzola, Mario.

In: Best Practice and Research: Clinical Haematology, Vol. 18, No. 2 SPEC. ISS., 06.2005, p. 251-263.

Research output: Contribution to journalArticle

@article{93704a9c4f1a4337993748bf1e28a143,
title = "Role of ferritin and ferroportin genes in unexplained hyperferritinaemia",
abstract = "A large body of evidence indicates that the level of serum ferritin parallels the concentration of storage iron within the body, regardless of the cell type in which it is stored. Elevated serum ferritin levels, in the absence of inflammation and liver disease, are currently taken to indicate increased iron stores and require further investigation to determine the site of iron overload. Until recently, the only genetic disorder with elevated serum ferritin levels known in Western countries was hereditary HLA-related HFE-related genetic haemochromatosis in Caucasians (HFE, OMIM 235200), and a high serum ferritin in apparently healthy persons was considered suggestive of this disease. In the last few years, at least two novel genetic disorders of iron metabolism presenting as unexplained hyperferritinaemia have been recognized. The first one is hereditary hyperferritinaemia/cataract syndrome (HHCS, OMIM 600886). HHCS arises from various point mutations or deletions within a protein binding sequence in the 5′-UTR of the L-ferritin mRNA that results in increased efficiency of L-ferritin translation. The second one is haemochromatosis type 4, or HFE4 (OMIM 606069), or ferroportin disease. In this latter condition, reticuloendothelial iron overload and hyperferritinaemia are caused by loss-of-function mutations in the SLC11A3 gene that mainly impair macrophage iron recycling. These genetic disorders should be taken into account in the differential diagnosis of unexplained hyperferritinaemia.",
keywords = "Cataract, Ferritin, Ferroportin, Hyperferritinaemia, Iron",
author = "Mario Cazzola",
year = "2005",
month = "6",
doi = "10.1016/j.beha.2004.08.025",
language = "English",
volume = "18",
pages = "251--263",
journal = "Best Practice and Research in Clinical Haematology",
issn = "1521-6926",
publisher = "Bailliere Tindall Ltd",
number = "2 SPEC. ISS.",

}

TY - JOUR

T1 - Role of ferritin and ferroportin genes in unexplained hyperferritinaemia

AU - Cazzola, Mario

PY - 2005/6

Y1 - 2005/6

N2 - A large body of evidence indicates that the level of serum ferritin parallels the concentration of storage iron within the body, regardless of the cell type in which it is stored. Elevated serum ferritin levels, in the absence of inflammation and liver disease, are currently taken to indicate increased iron stores and require further investigation to determine the site of iron overload. Until recently, the only genetic disorder with elevated serum ferritin levels known in Western countries was hereditary HLA-related HFE-related genetic haemochromatosis in Caucasians (HFE, OMIM 235200), and a high serum ferritin in apparently healthy persons was considered suggestive of this disease. In the last few years, at least two novel genetic disorders of iron metabolism presenting as unexplained hyperferritinaemia have been recognized. The first one is hereditary hyperferritinaemia/cataract syndrome (HHCS, OMIM 600886). HHCS arises from various point mutations or deletions within a protein binding sequence in the 5′-UTR of the L-ferritin mRNA that results in increased efficiency of L-ferritin translation. The second one is haemochromatosis type 4, or HFE4 (OMIM 606069), or ferroportin disease. In this latter condition, reticuloendothelial iron overload and hyperferritinaemia are caused by loss-of-function mutations in the SLC11A3 gene that mainly impair macrophage iron recycling. These genetic disorders should be taken into account in the differential diagnosis of unexplained hyperferritinaemia.

AB - A large body of evidence indicates that the level of serum ferritin parallels the concentration of storage iron within the body, regardless of the cell type in which it is stored. Elevated serum ferritin levels, in the absence of inflammation and liver disease, are currently taken to indicate increased iron stores and require further investigation to determine the site of iron overload. Until recently, the only genetic disorder with elevated serum ferritin levels known in Western countries was hereditary HLA-related HFE-related genetic haemochromatosis in Caucasians (HFE, OMIM 235200), and a high serum ferritin in apparently healthy persons was considered suggestive of this disease. In the last few years, at least two novel genetic disorders of iron metabolism presenting as unexplained hyperferritinaemia have been recognized. The first one is hereditary hyperferritinaemia/cataract syndrome (HHCS, OMIM 600886). HHCS arises from various point mutations or deletions within a protein binding sequence in the 5′-UTR of the L-ferritin mRNA that results in increased efficiency of L-ferritin translation. The second one is haemochromatosis type 4, or HFE4 (OMIM 606069), or ferroportin disease. In this latter condition, reticuloendothelial iron overload and hyperferritinaemia are caused by loss-of-function mutations in the SLC11A3 gene that mainly impair macrophage iron recycling. These genetic disorders should be taken into account in the differential diagnosis of unexplained hyperferritinaemia.

KW - Cataract

KW - Ferritin

KW - Ferroportin

KW - Hyperferritinaemia

KW - Iron

UR - http://www.scopus.com/inward/record.url?scp=14544267566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14544267566&partnerID=8YFLogxK

U2 - 10.1016/j.beha.2004.08.025

DO - 10.1016/j.beha.2004.08.025

M3 - Article

C2 - 15737888

AN - SCOPUS:14544267566

VL - 18

SP - 251

EP - 263

JO - Best Practice and Research in Clinical Haematology

JF - Best Practice and Research in Clinical Haematology

SN - 1521-6926

IS - 2 SPEC. ISS.

ER -